Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, announced a GenomeWeb-hosted webinar exploring how RNA Sequencing (RNA-Seq) can help address persistent diagnostic challenges in rare genetic disease.
What:
Christine Eng, MD, Chief Medical Officer and Chief Quality Officer at Baylor Genetics, will present a webinar titled “When the Genome isn’t Enough: Closing Rare Disease Gaps with RNA Sequencing.” The session will examine how RNA-Seq provides functional evidence that can help clarify variants of uncertain significance and improve diagnostic outcomes for patients who remain undiagnosed after genome sequencing.
Attendees will learn how Baylor Genetics uses targeted reflex RNA-Seq to complement genome sequencing, support variant interpretation, and help uncover answers beyond the genome for patients with suspected rare genetic diseases.
Who:
Christine Eng, MD, Chief Medical Officer and Chief Quality Officer, Baylor Genetics
When:
Date: August 24, 2026
Time: 9 a.m PDT / 12 p.m EDT / 6 p.m CEST
Register here.
